ivWatch Patient Monitor and SmartTouch Sensor Named One of the Most Interesting Innovations of 2023 by PM360

12.15.2023

Newport News, VA, December 15, 2023 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, included ivWatch in its annual Innovations Issue, which highlights the most interesting advancements in the life sciences, healthcare, and marketing in 13 categories. ivWatch’s patented Patient Monitor and SmartTouch Sensor were included within the Health Technology, Non-Consumer category.

​​ivWatch is the inventor and manufacturer of the only FDA-cleared and CE Marked continuous IV site monitoring technology. With a robust patent portfolio of 71 patents around the world protecting its core technologies and reinforcing its commitment to current and future innovations, the medical device technology works as a monitoring system to notify clinicians in real time of an IV infiltration or extravasation. The innovation is proven to detect fluid leaking outside of the vein into the surrounding tissue at the earliest stages to significantly reduce patient harm and improve outcomes in IV therapy.

“PM360 has long been one of the most read and most authoritative media outlets in our industry, and to be honored alongside so many other cutting-edge companies with this award is a testament to the constant commitment to innovation of our team,” said Erin Wendell, ivWatch’s Chief Marketing Officer. “At ivWatch, we are not just selling products. We are solving a major global problem in healthcare by revolutionizing vascular access practices with technology. We embrace science by creating real innovations that give clinicians an advantage to make IV therapy safer.”

Now, in its 12th year, PM360’s Innovations Issue is published each December. This issue was established as the industry’s first-ever guide to the year’s most innovative advancements and has since become a premier resource. This year, the issue expanded to include 13 categories: Artificial Intelligence; Clinical Trials; Consumer Tech and Wellness; Core Business Processes; Data and Cybersecurity; Employee Acquisition, Development, and Programs; Health Technology Non-Consumer; Life Sciences; Marketing Technology or Services; Metaverse; Payers/Insurance Companies; Startups; and Telehealth/Telemedicine.

In total, 56 innovations were selected by PM360’s editorial staff for inclusion in the issue out of hundreds of submissions.    

“We know the importance of innovation, which is why we expanded this issue to include the most fascinating and ground-breaking achievements being made in all areas of life sciences, healthcare, and marketing,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “The innovations we selected are changing how our industry operates to create better ways to develop treatments, run companies, educate physicians, improve diagnosis, and much more to ultimately find better ways to serve patients.”

All of this year’s selections can be found at: https://www.pm360online.com/pm360-presents-the-2023-innovators.

About ivWatch

ivWatch, LLC  is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, Instagram @ivWatchLLC and LinkedIn @ivWatch-LLC, or visit www.ivWatch.com. 

About PM360 

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.